Sunscreen Firm Warned, Natural Balms Among Recent Recalls: Consumer Health News
Executive Summary
Korean OTC firm Seidni has GMP, sunscreen labeling problems; DXM abuse by teens remains at 3%, annual survey shows; GMP deviations among reasons behind recent OTC recalls.
You may also be interested in...
States’ Limits On OTC Dextromethorphan Sales Could Force Congress’ Hand
US House legislation banning the sale of DXM OTCs to consumers under age 18 likely stands the same chance right now as previous versions that have failed, but CHPA expects an increasing number of state laws could spur future action.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.